Skip to main content
Caplight Logo









BioCurie

BioCurie

Private
Wilmington, DelawareHealthcare & Life Scienceshttps://biocurie.ai/

Last Round

Grant

Mar 12, 2026

Total Funding Raised

$11.6M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

BioCurie is a TechBio company that develops an AI-driven software platform to optimize the manufacturing and development of cell, gene, and RNA therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Vertical SaaS, Smart Manufacturing

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts

AI Layer

Infrastructure

Keywords

biomanufacturingcell and gene therapyCGTprocess developmentmechanistic modelingbioprocess optimizationdigital twingenomic medicinevertical SaaSAI infrastructureCDMOtechbioin silicoRNA therapybiopharma software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioCurie Comparables

Compare BioCurie with similar companies based on industry and business-model similarity.

BioCurie comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AiCella
81%
DataHow AG
81%
BioRaptor
78%

BioCurie Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 12, 2026
SeedOct 14, 2025

Key People

Founding team and executive leadership

Irene Rombel

CEO and Co-Founder

Founding Team

BioCurie Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 295% MoM, reaching 2.2K.

  • May 27, 2026

    Grew 38% QoQ, from 8 to 11 employees.

BioCurie Filings

Explore SEC and related filing metadata, where available.

BioCurie filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioCurie's valuation, stock price, and market status.

Is BioCurie a public or private company?

BioCurie is a private company.

What is the current stock price of BioCurie?

BioCurie is a private company with no public stock price. No recent secondary market data is available.

How much is BioCurie worth (valuation)?

Valuation information for BioCurie is not publicly available.

Can I buy BioCurie stock?

BioCurie shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioCurie's last funding round?

BioCurie's most recent funding round was Grant on March 12, 2026.

Who are the main investors in BioCurie?

Key investors in BioCurie include Creative Destruction Lab, Delaware Division of Small Business, Cure by Deerfield, ARPA-H.

Will BioCurie IPO soon?

No public IPO plans have been announced for BioCurie.

How can I track BioCurie secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioCurie's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWilmington, Delaware
Employee Range11
Year Founded2021
Last FundingMar 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?